ROPIVACAINE HYDROCHLORIDE INJECTION USP
ROPIVACAINE HYDROCHLORIDE INJECTION USP
Discontinued
DIN Number
02347822
Drug Class
Human
Market Date
Dec 14, 2010
Company
HC
Pfizer Canada Ulc
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02347822
AIG Number0133273003
Classification & Schedule
C
Drug Class
Human
S
Schedule
Ethical
A
ATC Code
N01BB09 ROPIVACAINE
Product Specifications
Dosage FormSolution
Route of AdministrationBlock/Infiltration
,
Epidural
AHFS Classification72:00.00
Health Canada Classification
ACTIVE INGREDIENTS (1)
ROPIVACAINE HYDROCHLORIDEActive
Strength: 5 MG / ML
Monograph: ROPIVACAINE HYDROCHLORIDE
